as on September 17, 2025 at 1:29 am IST
Day's Low
Day's High
11.07%
Downside
0.76%
Upside
52 Week's Low
52 Week's High
21.37%
Downside
576.72%
Upside
Check Alzamend Neuro Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$7.6M
EPS (TTM)
-11.88
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-6.2M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Alzamend Neuro Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $7.6M | NA | NA | 0.00% | |
BUY | $61.1B | 251.26% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.2B | 47.46% | 28.09 | 31.86% | |
BUY | $59.6B | 0.6% | 14.1 | 31.37% |
The Alzamend Neuro Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Alzamend Neuro Inc investment value today
Current value as on today
₹20,863
Returns
Returns from Alzamend Neuro Inc Stock
Dollar Returns*
₹4,867 (+4.87%)
Based on 8 analysts
75.00%
Buy
25.00%
Hold
0.00%
Sell
Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Alzamend Neuro Inc. Average target price of $45
Get share price movements and forecasts by analysts on Alzamend Neuro Inc.
What analysts predicted
94.18%UPSIDE
Target Price
$45
Current Price
$2.62
Analyzed by
8 Analysts
Target
$45.00
Alzamend Neuro Inc target price $45, a slight upside of 94.18% compared to current price of $2.62. According to 8 analysts rating.
Search interest for Alzamend Neuro Inc Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 216.4%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 156.3%
Price Dip
In the last 3 months, ALZN stock has moved down by -23.9%
Organisation | Alzamend Neuro Inc |
Headquarters | 3480 Peachtree Road NE, Atlanta, GA, United States, 30326 |
CEO | Mr. Stephan Jackman |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Stephan Jackman | CEO & Director |
Mr. Milton Charles Ault III | Founder & Vice Chairman |
Mr. David J. Katzoff | Chief Financial Officer |
Mr. Henry C. W. Nisser Esq. | Executive VP, General Counsel & Director |
Mr. Kenneth S. Cragun CPA | Senior Vice President of Finance |
Alzamend Neuro Inc share price today is $2.62 as on at the close of the market. Alzamend Neuro Inc share today touched a day high of $2.64 and a low of $2.33.
Alzamend Neuro Inc share touched a 52 week high of $17.73 on and a 52 week low of $2.06 on . Alzamend Neuro Inc stock price today i.e. is closed at $2.62,which is 85.22% down from its 52 week high and 27.18% up from its 52 week low.
Alzamend Neuro Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Alzamend Neuro Inc (ALZN) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Alzamend Neuro Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Alzamend Neuro Inc share’s latest price of $2.62 as on September 17, 2025 at 1:29 am IST, you will get 3.8168 shares of Alzamend Neuro Inc. Learn more about
fractional shares .